However, the data for clinical remission which followed this trend did not reach statistical significance, probably due to the limited sample size.
← all excerpts
Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies.
1
—
—